Free insulin-like growth factor-I and cognitive function in older persons living in community

Growth Hormone and IGF Research

Volumn 17, Issue 1, 2007, Pages 58-66

  Landi, Francesco ^a   Capoluongo, Ettore ^a   Russo, Andrea ^a   Onder, Graziano ^a   Cesari, Matteo ^a,b   Lulli, Paola ^a   Minucci, Angelo ^a   Pahor, Marco ^b   Zuppi, Cecilia ^a   Bernabei, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cognitive performance; Frail elderly; Free IGF I; IGFBP 3

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

AGED; AGING; ALCOHOL ABUSE; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; COMMUNITY LIVING; COMPREHENSION; CONFOUNDING VARIABLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DATA ANALYSIS; DECISION MAKING; DEPRESSION; DIABETES MELLITUS; DRUG USE; EDUCATION; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROCEDURAL MEMORY; PROTEIN BLOOD LEVEL; SHORT TERM MEMORY; SKILL; SMOKING; SPEECH DISORDER; THYROID DISEASE; VERBALIZATION;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; COGNITION; COHORT STUDIES; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; ITALY; MALE; MEMORY DISORDERS; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS;

EID: 33847188027     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2006.11.001     Document Type: Article

References (39)

1. Fratiglioni L., De Ronchi D., and Aguero-Torres H. Worldwide prevalence and incidence of dementia. Drug. Aging 15 (1999) 365-375
2. Jorm A.F., and Jolley D. The incidence of dementia: a meta-analysis. Neurology 51 3 (1998) 728-733
3. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., and Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (2002) 3223-3229
4. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., Wilson R.S., and Scherr P.A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 (2002) 3230-3237
5. van Dam P.S., and Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur. J. Pharmacol. 490 (2004) 87-95
6. Carro E., and Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. Eur. J. Pharmacol. 490 (2004) 127-133
7. Bondy C.A., and Cheng C.M. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490 (2004) 25-31
8. Burman P., and Deijen J.B. Quality of life and cognitive function in patients with pituitary insufficiency. Psychother. Psychosom. 67 (1998) 154-167
9. Aleman A., Verhaar H.J., De Haan E.H., de Vries W.R., Samson M.M., Drent M.L., van der Veen E.A., and Koppeschaar H.P. Insulin-like growth factor-I and cognitive function in healthy older men. J. Clin. Endocrinol. Metab. 84 (1999) 471-475
10. Papadakis M.A., Grady D., Tierney M.J., Black D., Wells L., and Grunfeld C. Insulin-like growth factor 1 and functional status in healthy older men. J. Am. Geriatr. Soc. 43 (1995) 1350-1355
11. Rollero A., Murialdo G., Fonzi S., Garrone S., Gianelli M.V., Gazzerro E., Barreca A., and Polleri A. Relationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 38 (1998) 73-79
12. Morley J.E., Kaiser F., Raum W.J., Perry III H.M., Flood J.F., Jensen J., Silver A.J., and Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc. Natl. Acad. Sci. 94 (1997) 7537-7542
13. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M.R., Rizzo M.R., Carella C., and Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J. Clin. Endocrinol. Metab. 82 (1997) 2204-2209
14. Kalmijn S., Janssen J.A., Pols H.A., Lamberts S.W., and Breteler M.M. A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J. Clin. Endocrinol. Metab. 85 (2000) 4551-4555
15. Dik M.G., Pluijm S.M., Jonker C., Deeg D.J., Lomecky M.Z., and Lips P. Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol. Aging 24 (2003) 573-581
16. Morris J.N., Fries B.E., and Meher D.R. MDS Cognitive Performance Scale. J. Gerontol. 49 (1994) M174-M182
17. Morris J.N., Fries B.E., Steel K., Ikegami N., Bernabei R., Carpenter G.I., et al. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J. Am. Geriatr. Soc. 45 (1997) 1017-1024
18. Landi F., Russo A., Cesari M., et al. The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin. Exp. Res. 17 (2005) 486-493
19. Landi F., Sgadari A., Cipriani L., Castellani M., Pahor M., Carbonin P., et al. A simple program to train case managers in community elderly care. Aging Clin. Exp. Res. 8 (1996) 211-218
20. Morris J.N., Fries B.E., Bernabei R., Ikegami N., Gilgen R., and Steel K. RAI - Home Care assessment manual (1996), InterRAI Corporation, Washington, DC
21. Landi F., Tua E., Onder G., Carrara B., Sgadari A., Rinaldi C., and Bernabei R. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med. Care 38 12 (2000) 1184-1190
22. Ferrucci L., Bandinelli S., Benvenuti E., Di Iorio A., Macchi C., and Harris T.B. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J. Am. Geriatr. Soc. 48 (2000) 1618-1625
23. Diagnostic and Statistical Manual of Mental Disorders - Fourth Edition (DSM-IV) (1994), American Psychiatric Association, Washington DC
24. Frederiksen K., Tariot P., and DeJonghe E. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scale. J. Am. Geriatr. Soc. 44 (1996) 305-309
25. Hartmaier S.L., Sloane P.D., and Guess H.A. Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J. Gerontol. 50 (1995) M128-M133
26. Singer C.F., Mogg M., Koestler W., Pacher M., Marton E., Kubista E., and Schreiber M. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size. Clin. Cancer Res. 15 (2004) 4003
27. Huysman M.W., Hokken-Koelega A.C., Hop W.C., and Sauer P.J. Effect of dexamethasone treatment on serum GH, IGF-I, and the binding proteins IGFBP-1 and -3 in ventilated very preterm infants. Pediatr. Res. 54 (2003) 37
28. Lobiezz P.E., Zhu T., Graichen R., and Goh E.L. Growth hormone, insulin-like growth factor I and the CNS: localization, function and mechanism of action. Growth Horm. IGF Res. 10 (2000) 51S-56S
29. van Dam P.S., Aleman A., de Vries W.R., Deijen E.A., van der Ven E.A., de Haan E.H., and Koppeschaar H.P. Growth hormone, insulin-like growth factor I and cognitive function in adults. Growth Horm. IGF Res. 10 (2000) 69S-73S
30. Arwert L.I., Deijen J.B., and Drent M.L. The relationship between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm. IGF Res. 15 (2005) 416-422
31. Trejo J.L., Carro E., Lopez-Lopez C., and Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm. IGF Res. 14 (2004) S39-S43
32. Araujo D.M., Lapchak P.A., Collier B., Chabot J.G., and Quirion R. Insulin-like growth factor-1 (somatomedin-C) receptors in the rat brain: distribution and interaction with the hippocampal cholinergic system. Brain Res. 484 (1989) 130-138
33. Nilsson L., Sara V.R., and Nordberg A. Insulin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices. Neurosci. Lett. 88 (1988) 221-226
34. Lynch C.D., Lyons D., Khan A., Bennett S.A., and Sonntag W.E. Insulin-like growth factor-1 selectively increases glucose utilization in brains of aged animals. Endocrinology 142 (2001) 506-509
35. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., and Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc. Natl. Acad. Sci. 97 (2000) 10236-10241
36. Brywe K.G., Mallard C., Gustavsson M., Hedtjarn M., Leverin A.L., Wang X., Blomgren K., Isgaard J., and Hagberg H. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?. Eur. J. Neurosci. 21 (2005) 1489-1502
37. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 8 (2002) 1390-1397
38. G. Onder, R. Liperoti, A. Russo, M. Soldato, E. Capoluongo, S. Volpato, M. Cesari, F. Ameglio, R. Bernabei, F. Landi, Body mass index, free insulin growth factor 1 and physical function among older adults: results from the IlSIRENTE study, Am. J. Physiol. Endocrinol. Metab., 2006, May 9, Epub ahead of print.
39. Capoluongo E., Pitocco D., Lulli P., Minacci A., Santonocito C., Manto A., Zuppi C., Ghirlanda G., and Ameglio F. Inverse correlation between serum free IGF-I and IGFBP-3 levels and blood pressure in patients affected with type 1 diabetes. Cytokine 34 5-6 (2006) 303-311